CD47 Blockade and Rituximab in Non-Hodgkin’s Lymphoma
- PMID: 30702240
- DOI: 10.1056/NEJMc1816156
CD47 Blockade and Rituximab in Non-Hodgkin’s Lymphoma
Comment in
-
CD47 Blockade and Rituximab in Non-Hodgkin's Lymphoma.N Engl J Med. 2019 Jan 31;380(5):497-498. doi: 10.1056/NEJMc1816156. N Engl J Med. 2019. PMID: 30699313 No abstract available.
Comment on
-
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma.N Engl J Med. 2018 Nov 1;379(18):1711-1721. doi: 10.1056/NEJMoa1807315. N Engl J Med. 2018. PMID: 30380386 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials